H.R. 5160 · 119th Congress · Health

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Reauthorizes bone marrow and cord blood transplant programs through fiscal year 2031. AI-read

Passed House579 words Introduced Sep 4, 2025 · Latest action Jul 21, 2026

How far it has goneStage 4 of 6
  1. IntroducedSep 4, 2025 Done
  2. CommitteeReported Jul 2, 2026 Done
  3. House floorPassed by voice vote · Jul 20, 2026 Done
  4. Senate floorAwaiting vote Current stage
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA).

The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research.

Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Congressional Research Service · summary of “Reported to House” version · Jul 2, 2026

Who lobbies on it

1 organization · 1 filing · Q3 2025–Q3 2026

See which of this bill’s sponsors and cosponsors got money from American Benefits Council’s PAC → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. American Benefits Council 1 of 5 quarters
    “…HR 5160 / S. 2403”

    $830K lobbying spend in 2026 to date, all issuesQ1 2026 filing

Organizations that named H.R. 5160 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

16 actions · newest first
  1. Jul 21, 2026Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
  2. Jul 20, 2026Motion to reconsider laid on the table Agreed to without objection.
  3. Jul 20, 2026On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
  4. Jul 20, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Show all 16 actionsShow fewer
  1. Jul 20, 2026DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
  2. Jul 20, 2026Considered under suspension of the rules. (consideration: CR H4642-4643)
  3. Jul 20, 2026Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
  4. Jul 2, 2026Placed on the Union Calendar, Calendar No. 629.
  5. Jul 2, 2026Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
  6. May 21, 2026Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
  7. May 21, 2026Committee Consideration and Mark-up Session Held
  8. May 13, 2026Forwarded by Subcommittee to Full Committee by Voice Vote.
  9. May 13, 2026Subcommittee Consideration and Mark-up Session Held
  10. Sep 4, 2025Referred to the Subcommittee on Health.
  11. Sep 4, 2025Referred to the House Committee on Energy and Commerce.
  12. Sep 4, 2025Introduced in House

What members said about it